ATA745276A - Verfahren zur herstellung von neuen 1benzazolylalkylpiperidinen und ihren salzen mit saeuren - Google Patents
Verfahren zur herstellung von neuen 1benzazolylalkylpiperidinen und ihren salzen mit saeurenInfo
- Publication number
- ATA745276A ATA745276A AT0745276A AT745276A ATA745276A AT A745276 A ATA745276 A AT A745276A AT 0745276 A AT0745276 A AT 0745276A AT 745276 A AT745276 A AT 745276A AT A745276 A ATA745276 A AT A745276A
- Authority
- AT
- Austria
- Prior art keywords
- salts
- acids
- producing new
- producing
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62072775A | 1975-10-08 | 1975-10-08 | |
| US05/713,309 US4035369A (en) | 1975-10-08 | 1976-08-10 | 1-Benzazolylalkyl-4-substituted-piperidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA745276A true ATA745276A (de) | 1981-05-15 |
| AT365185B AT365185B (de) | 1981-12-28 |
Family
ID=27088773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0745276A AT365185B (de) | 1975-10-08 | 1976-10-07 | Verfahren zur herstellung von neuen 1benzazolylalkylpiperidinen und ihren salzen mit saeuren |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4035369A (de) |
| JP (1) | JPS5246082A (de) |
| AT (1) | AT365185B (de) |
| AU (1) | AU511834B2 (de) |
| BG (1) | BG27542A3 (de) |
| CA (1) | CA1085853A (de) |
| CH (1) | CH630915A5 (de) |
| CS (1) | CS225101B2 (de) |
| DE (1) | DE2645125A1 (de) |
| DK (1) | DK151801C (de) |
| EG (1) | EG12969A (de) |
| ES (1) | ES452200A1 (de) |
| FI (1) | FI63228C (de) |
| FR (1) | FR2346009A1 (de) |
| GB (1) | GB1532546A (de) |
| GR (1) | GR61672B (de) |
| HU (1) | HU174927B (de) |
| IE (1) | IE43951B1 (de) |
| IL (1) | IL50631A (de) |
| IT (1) | IT1069293B (de) |
| LU (1) | LU75954A1 (de) |
| NL (1) | NL7611085A (de) |
| NO (1) | NO144926C (de) |
| NZ (1) | NZ182134A (de) |
| PH (1) | PH15417A (de) |
| PL (1) | PL106815B1 (de) |
| PT (1) | PT65688B (de) |
| RO (1) | RO69904A (de) |
| SE (1) | SE417610B (de) |
| SU (1) | SU663306A3 (de) |
| YU (1) | YU39976B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200641A (en) * | 1976-12-21 | 1980-04-29 | Janssen Pharmaceutica, N.V. | 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives |
| US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| IE810250L (en) * | 1980-02-11 | 1981-08-11 | Berlex Lab | N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines. |
| US4254127A (en) * | 1980-04-03 | 1981-03-03 | Janssen Pharmaceutica, N.V. | 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives |
| DE3442757A1 (de) * | 1984-11-23 | 1986-05-28 | Wella Ag, 6100 Darmstadt | Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate |
| KR930005004B1 (ko) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
| FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
| FR2702214B1 (fr) * | 1993-03-05 | 1995-04-14 | Adir | Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| GB9418326D0 (en) * | 1994-09-12 | 1994-11-02 | Lilly Industries Ltd | Pharmaceutical compounds |
| ATE247114T1 (de) | 1994-09-12 | 2003-08-15 | Lilly Co Eli | Serotonergische modulatoren |
| GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
| GB9613423D0 (en) * | 1996-06-26 | 1996-08-28 | Lilly Industries Ltd | Pharmaceutical compounds |
| WO2008035066A2 (en) * | 2006-09-19 | 2008-03-27 | Cipla Limited | Processes for the preparation of ciclesonide and its crystal form |
| CN101759693B (zh) * | 2008-12-23 | 2011-09-14 | 江苏恩华药业股份有限公司 | 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用 |
| AU2022237901A1 (en) * | 2021-03-19 | 2023-09-28 | Centre National De La Recherche Scientifique | Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633495A (de) * | 1962-06-13 | |||
| US3225052A (en) * | 1964-05-06 | 1965-12-21 | Janssen Pharmaceutica Nv | Benzimidazolinyl piperidine derivatives |
| FR1573739A (de) | 1968-07-26 | 1969-07-04 | ||
| US3635982A (en) * | 1969-04-08 | 1972-01-18 | American Home Prod | Amino-substituted-quinoxalinyloxazolidines and -oxazines |
-
1976
- 1976-08-10 US US05/713,309 patent/US4035369A/en not_active Expired - Lifetime
- 1976-09-22 NZ NZ182134A patent/NZ182134A/xx unknown
- 1976-09-23 AU AU18078/76A patent/AU511834B2/en not_active Expired
- 1976-09-28 PH PH18950A patent/PH15417A/en unknown
- 1976-10-01 CA CA262,478A patent/CA1085853A/en not_active Expired
- 1976-10-05 EG EG605/76A patent/EG12969A/xx active
- 1976-10-05 GR GR51849A patent/GR61672B/el unknown
- 1976-10-05 FR FR7629928A patent/FR2346009A1/fr active Granted
- 1976-10-06 DE DE19762645125 patent/DE2645125A1/de active Granted
- 1976-10-06 IT IT51612/76A patent/IT1069293B/it active
- 1976-10-06 GB GB41465/76A patent/GB1532546A/en not_active Expired
- 1976-10-06 CH CH1265376A patent/CH630915A5/de not_active IP Right Cessation
- 1976-10-07 IE IE2212/76A patent/IE43951B1/en unknown
- 1976-10-07 ES ES452200A patent/ES452200A1/es not_active Expired
- 1976-10-07 SE SE7611137A patent/SE417610B/xx not_active IP Right Cessation
- 1976-10-07 JP JP51119933A patent/JPS5246082A/ja active Granted
- 1976-10-07 NO NO763424A patent/NO144926C/no unknown
- 1976-10-07 PT PT65688A patent/PT65688B/pt unknown
- 1976-10-07 IL IL50631A patent/IL50631A/xx unknown
- 1976-10-07 AT AT0745276A patent/AT365185B/de active
- 1976-10-07 LU LU75954A patent/LU75954A1/xx unknown
- 1976-10-07 FI FI762865A patent/FI63228C/fi not_active IP Right Cessation
- 1976-10-07 NL NL7611085A patent/NL7611085A/xx not_active Application Discontinuation
- 1976-10-07 PL PL1976192890A patent/PL106815B1/pl not_active IP Right Cessation
- 1976-10-07 DK DK452076A patent/DK151801C/da not_active IP Right Cessation
- 1976-10-08 CS CS766511A patent/CS225101B2/cs unknown
- 1976-10-08 BG BG7634394A patent/BG27542A3/xx unknown
- 1976-10-08 HU HU76JA771A patent/HU174927B/hu not_active IP Right Cessation
- 1976-10-08 YU YU2480/76A patent/YU39976B/xx unknown
- 1976-10-08 SU SU762407707A patent/SU663306A3/ru active
- 1976-10-08 RO RO197687960Q patent/RO69904A/ro unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT374191B (de) | Verfahren zur herstellung von neuen substituierten acethydroxamsaeuren und deren salzen | |
| ATA942975A (de) | Verfahren zur herstellung von neuen 1-substituierten-4-benzylidenpiperidene und ihren salzen | |
| AT360024B (de) | Verfahren zur herstellung von neuen pyrimid-4- on- und-thion-derivaten und ihren salzen mit saeuren | |
| AT358045B (de) | Verfahren zur herstellung von neuen pyrimid-4- -on- und -thion-derivaten und ihrer salze mit saeuren | |
| AT365185B (de) | Verfahren zur herstellung von neuen 1benzazolylalkylpiperidinen und ihren salzen mit saeuren | |
| AT360533B (de) | Verfahren zur herstellung von neuen trans- -hexahydropyrido-indolen und ihren saeure- additionssalzen | |
| AT353970B (de) | Verfahren zur herstellung von neuen 7-methoxy- cephalosporinen und deren salzen | |
| ATA702976A (de) | Verfahren zur herstellung von neuen n-aryl-n- (4-piperidinyl)-arylacetamiden und ihren salzen | |
| AT353257B (de) | Verfahren zur herstellung von neuen dibenzo- furanderivaten und ihren salzen | |
| AT351559B (de) | Verfahren zur herstellung von neuen isothio- harnstoffaethern und ihren salzen mit saeuren | |
| ATA307175A (de) | Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen | |
| AT342049B (de) | Verfahren zur herstellung von neuen 4-oxo-4h-pyrano- (3,2-c)-chinolin-2-carbonsauren und ihren salzen | |
| AT342034B (de) | Verfahren zur herstellung von neuen 4,4-diphenyl-2-hydroxybutylaminen und ihren salzen | |
| ATA606175A (de) | Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen | |
| AT352724B (de) | Verfahren zur herstellung von neuen substi- tuierten sulfoximiden und deren salzen | |
| AT361624B (de) | Verfahren zur herstellung von neuen spectino- mycinderivaten und ihren salzen mit saeuren | |
| AT341529B (de) | Verfahren zur herstellung von neuen azatetracyclen und ihren salzen | |
| AT356122B (de) | Verfahren zur herstellung von neuen pyridazinonderivaten und ihren salzen mit saeuren | |
| AT358046B (de) | Verfahren zur herstellung von neuen trans-5a- -aryl-decahydrobenzazepinen und ihren saeure- additionssalzen | |
| AT358027B (de) | Verfahren zur herstellung von neuen indol- derivaten und ihren salzen | |
| AT357535B (de) | Verfahren zur herstellung von neuen 4-amino- transdecahydrochinolinderivaten und ihren saeureadditionssalzen | |
| ATA668277A (de) | Verfahren zur herstellung von neuen 4-hydroxy- indol-derivaten und ihren salzen | |
| ATA402479A (de) | Verfahren zur herstellung von neuen 5-aroyl-1,2 -dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carbon- saeuren und ihren salzen | |
| AT367750B (de) | Verfahren zur herstellung von neuen n2-arylsulfonyl-l-argininamiden und deren salzen | |
| ATA668177A (de) | Verfahren zur herstellung von neuen 4-hydroxy- indol-derivaten und ihren salzen |